HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux Investor Seeks Consent To Remove Board For Administrative “Failings”

This article was originally published in The Rose Sheet

Executive Summary

Parlux could fall under new management if a proposal put forth by stockholder Glenn H. Nussdorf wins the support of fellow investors

You may also be interested in...



Parlux Has “Enough" Celeb Fragrances, Says CEO, Reaffirming New Direction

Still reeling from the loss of the Guess fragrance license, which contributed to a 37% decline in sales for the third quarter, and in light of recent frustrations surrounding the launch of Reb'l Fleur by Rihanna, Parlux Fragrances CEO Frederick E. Purches maintains that it’s time for the company to change direction.

Parlux Has “Enough" Celeb Fragrances, Says CEO, Reaffirming New Direction

Still reeling from the loss of the Guess fragrance license, which contributed to a 37% decline in sales for the third quarter, and in light of recent frustrations surrounding the launch of Reb'l Fleur by Rihanna, Parlux Fragrances CEO Frederick E. Purches maintains that it’s time for the company to change direction.

Parlux Open To Acquisition While Aiming For Profitability In Fiscal 2011

Back in the hands of its founder, Frederick E. Purches, Parlux Fragrances is optimistic that it will return to profitability "in the near future"; meanwhile, the company would not object to being acquired if the right opportunity arose, Purches said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel